Department of Surgery, University of Iowa Hospitals and Clinics, Iowa City, IA, USA.
Holden Comprehensive Cancer Center, University of Iowa Hospitals and Clinics, Iowa City, IA, USA.
Ann Surg Oncol. 2023 Oct;30(10):6010-6021. doi: 10.1245/s10434-023-13890-w. Epub 2023 Aug 1.
Ultrasound-guided pectoralis muscle blocks (PECS I/II) are well established for postoperative pain control after mastectomy with reconstruction. However, optimal timing is unclear. We conducted a randomized controlled single-blinded single-institution trial comparing outcomes of block performed pre-incision versus post-mastectomy.
Patients with breast cancer undergoing bilateral mastectomy with immediate expander/implant reconstruction were randomized to receive ultrasound-guided PECS I/II either pre-incision (PreM, n = 17) or post-mastectomy and before reconstruction (PostM, n = 17). The primary outcome was the average pain score using the Numerical Rating Score during post-anesthesia care unit (PACU) and inpatient stay, with the study powered to detect a difference in mean pain score of 2. Secondary outcomes included mean pain scores on postoperative day (POD) 2, 3, 7, 14, 90, and 180; pain catastrophizing scores; narcotic requirements; PACU/inpatient length of stay; block procedure time; and complications.
No significant differences between the two groups were noted in average pain score during PACU (p = 0.57) and 24-h inpatient stay (p = 0.33), in the 2 weeks after surgery at rest (p = 0.90) or during movement (p = 0.30), or at POD 90 and 180 at rest (p = 0.42) or during movement (p = 0.31). Median duration of block procedure (PreM 7 min versus PostM 6 min, p = 0.21) did not differ. Median PACU and inpatient length of stay were the same in each group. Inpatient narcotic requirements were similar, as were length of stay and post-surgical complication rates.
Intraoperative ultrasound-guided PECS I/II block administered by surgeons following mastectomy had similar outcomes to preoperative blocks.
This trial is registered with Clinical Research Information Service (NCT03653988).
超声引导胸大肌阻滞(PECS I/II)已广泛应用于乳腺癌改良根治术后的术后镇痛。但最佳时机尚不清楚。我们进行了一项随机对照单盲单中心试验,比较了切开前和乳房切除术后行阻滞的效果。
接受双侧乳腺癌改良根治术及即刻扩张器/植入物重建的患者被随机分为切开前(PreM,n=17)或乳房切除术后及重建前(PostM,n=17)接受超声引导 PECS I/II 阻滞。主要结局是使用数字评分量表(Numeric Rating Scale)在麻醉后监护病房(PACU)和住院期间的平均疼痛评分,该研究有足够的效力检测平均疼痛评分的差异为 2。次要结局包括术后第 2、3、7、14、90 和 180 天的平均疼痛评分、疼痛灾难化评分、阿片类药物需求、PACU/住院时间、阻滞程序时间和并发症。
两组在 PACU 期间(p=0.57)和 24 小时住院期间(p=0.33)、术后 2 周静息时(p=0.90)或运动时(p=0.30)、术后 90 天和 180 天静息时(p=0.42)或运动时(p=0.31)的平均疼痛评分均无显著差异。阻滞程序的中位持续时间(PreM 7 分钟与 PostM 6 分钟,p=0.21)也没有差异。两组 PACU 和住院时间相同。住院期间阿片类药物需求相似,住院时间和术后并发症发生率也相似。
术中医师在乳房切除术后行超声引导胸大肌阻滞(PECS I/II)与术前阻滞效果相似。
本试验在临床研究信息服务处(NCT03653988)注册。